$CDRE SEC Filings

Filed On	Filing
30 Sep 2026	SCHEDULE 13D/A
26 Aug 2026	Form 4: Kanders Warren B, Director Sold 65,431 shares ($2.17M) · Sold 34,569 shares ($1.16M) · Sold 100,000 shares ($3.19M)
25 Aug 2026	144
24 Aug 2026	144
19 Aug 2026	Form 4: Williams Brad, PRESIDENT Received 42,770 shares by exercise or conversion ($1M) · Received 45,972 shares by exercise or conversion ($944K) · Sold 88,742 shares ($2.95M)
17 Aug 2026	144
07 Aug 2026	EFFECT
07 Aug 2026	8-K/A: Results of Operations and Financial Condition Grew Quarterly Net Sales 32% and Gross Profit 36% Year-Over-Year
06 Aug 2026	SCHEDULE 13G/A
05 Aug 2026	S-4/A
05 Aug 2026	10-Q
05 Aug 2026	8-K: Results of Operations and Financial Condition
29 Jul 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
23 Jun 2026	Form 4: Kanders Warren B, Director Sold 25,000 shares ($697K) · Sold 50,000 shares ($1.37M)
18 Jun 2026	Form 4: Kissel Mary E., Director Granted 17,393 Stock Option (right to purchase)
18 Jun 2026	Form 4: Quigley William G Iii, Director Granted 17,393 Stock Option (right to purchase)
18 Jun 2026	SCHEDULE 13D/A
18 Jun 2026	Form 4: Norton Hamish, Director Granted 17,393 Stock Option (right to purchase)
18 Jun 2026	Form 4: Sokolow Nicolas, Director Granted 17,393 Stock Option (right to purchase)
18 Jun 2026	Form 4: Browers Blaine, CHIEF FINANCIAL OFFICER Granted 118,000 Restricted Stock Units · Granted 207,500 Stock Option (right to purchase)

Comments